| In its biotechnology industry India is a proud | | | | markets of US and Europe, which will further |
| contributor of more than $700 million in annual | | | | encourage companies to enhance their R&D |
| revenues. With a growth of 40% over the past | | | | with the objective of patenting their own high-end |
| year, she is second only to United States in the | | | | products. In its market research report, |
| total number of FDA-approved drug | | | | “Indian Biotechnology Market Outlook |
| manufacturing plants. The various factors | | | | (2006)” RNCOS specialists believe that |
| accounting for India’s blossoming | | | | although Indian biotechnology has just started to |
| biotechnology industry are skilled laborers, low | | | | develop and holds only 1% of the global |
| costs, new patent protections and a pool of | | | | biotechnology market, it is poised for a favorable |
| patients ready for clinical trials. Indian companies | | | | growth with an expected world market share of |
| are ready learners with its good number of | | | | 10% over the next five years. The report gives |
| educated scientists. India therefore stands as a | | | | a fair picture of the future Indian biotech market, |
| good destination for manufacturers and | | | | the initiatives and policies of central and state |
| marketers. Several European companies and US | | | | governments covering all segments of the |
| are prompted to set up their units in this country. | | | | market. Having made an intensive SWOT analysis |
| They also contemplate on forming contracts with | | | | the report analyzes the sector in terms of size, |
| Indian firms for drug-development research, clinical | | | | demand, and foreign and domestic markets for |
| trials and research-data analysis. According to | | | | 2005 while making forecasts till 2010. Finally the |
| industry experts India is to soon become a | | | | report lists company profiles of 20 major |
| powerful player in global biotechnology and all by | | | | companies in the biotech industry including Shantha |
| its own merit and may even pose a threat to | | | | Biotechnics, Biocon, Bharat Biotech, Wockhardt, |
| other nations. To further support this situation, | | | | Serum Institute of India, Zydus Cadila, and |
| India is already acquiescing to World Trade | | | | Aventis Pharma. The report can make useful |
| Organization (WTO) patent protections. This would | | | | reading for this sector’s technicians, |
| enable Indian firms to find a base in developed | | | | manufacturers and researchers. |